Navigation Links
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card
Date:11/23/2009

SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pain and inflammation associated with primary dysmenorrhea and acute tendinitis and bursitis. It is also designed for patients suffering from rheumatoid arthritis or osteoarthritis who may be receiving other therapies and need additional anti-inflammatory/analgesic activity for a limited time. The Dose Card provides a ten day, tapered dose regimen in a single blister pack, with three days of NAPRELAN therapy at the maximum daily dose of 1,500 mg (i.e., two 750 mg tablets), followed by a taper to 1,000 mg per day (two 500 mg tablets) for an additional seven days of therapy.

Commenting on NAPRELAN Dose Card, Victory's Chief Executive Officer Matthew Heck stated, "This product concept is the result of substantial input from our clinical advisors and other members of the pain management community. It was designed to enable healthcare providers to treat pain and inflammation aggressively for a limited period of time and then taper NAPRELAN back to a standard dosage strength. This customized dosage regimen in a single prescription and product configuration will aid in patient compliance. We are excited about the prospects for NAPRELAN Dose Card based upon market feedback."

Victory will promote NAPRELAN Dose Card through its 160 person U.S. field sales organization.

About Victory Pharma

Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring, developing, and marketing products to treat pain and related conditions. Victory markets its lead product, NAPRELAN® (naproxen sodium) Controlled-Release Tablets and other pain products to pain m
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Researchers notch a victory toward new kind of cancer drug
2. Stupak Amendment Passes in Final House Health Care Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.
3. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
4. Mother & Daughter Celebrate Victory Over Meth
5. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
6. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
7. President Obama Delivers Historic Victory for Americas Kids and Health over Tobacco
8. American College of Chest Physicians Celebrates the Nations Victory for Tobacco Control
9. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... could lead to potential new treatments for breaking the ... , Fibrosis, or scarring, is a hallmark of the ... can lead to serious organ damage and, in some ... centers on findings made by Swati Bhattacharyya, PhD, research ... a specific protein plays in promoting fibrosis. , ...
(Date:4/17/2014)... that could be used to provide relief from ... made the discovery when researching how pain occurs ... , Dr Marzia Malcangio said: "We have been ... our findings could help chemotherapy patients who suffer ... effect of some chemotherapy drugs (such as vincristine) ...
(Date:4/17/2014)... School of Medicine report that older women, plucky individuals ... are more likely to be compassionate toward strangers than ... this month,s issue of the International Journal of ... with better health and well-being as we age, the ... outcomes of individuals whose deficits in compassion put them ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2
... SILVER SPRING, Md., Dec. 24 The American Nurses Association (ANA), ... for passing H.R. 3590, " The Patient Protection and Affordable ... vote of 60-39. ANA had urged passage of the legislation and ... members of Congress, was read on the Senate floor by Majority ...
... , , WASHINGTON, Dec. 24 ... Senate voted to pass the Patient Protection and Affordable Care ... bill on Christmas Eve, after overcoming a series of procedural ... stop the bill from ever reaching the Senate floor for ...
... Dec. 24 The American ... of legislation that holds the promise of more comprehensive coverage ... those without. , We are pleased that the ... our association,s principles for comprehensive health reform, and that the ...
... 24 The following statement is attributable to J. James ... Senate took an historic vote to improve our nation,s health ... strengthening the private insurance market to better serve the patients ... the bill because it contains a number of key improvements ...
... well-tolerated, researchers say , WEDNESDAY, Dec. 23 (HealthDay News) -- ... an effective treatment for Ewing,s sarcoma, a cancer that affects ... boys. , The drug must undergo two more phases of ... 23 online edition of The Lancet Oncology . , ...
... before proposal can become law , THURSDAY, Dec. 24 (HealthDay ... Eve gift on Thursday with passage of a landmark health ... Americans. , Obama said the Senate bill contains 95 percent ... inauguration on Jan. 20. "Every single criteria for reform that ...
Cached Medicine News:Health News:Senate Passes Landmark Health Care Reform Bill 2Health News:DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People 2Health News:APA Statement on Senate Passage of Health Care Reform Legislation 2Health News:AMA: Senate Bill Passage Historic, More Work to Do in Conference 2Health News:Senate Passes Health Reform Package 2Health News:Senate Passes Health Reform Package 3Health News:Senate Passes Health Reform Package 4
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the fourth quarter of 2013 will be approximately ... $208 million. "Our full-year revenue growth of ...
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new SLIC ... guide with accompanying instrumentation to place and insert the ... the soft tissue (e.g. ligament) repair or reconstruction as ... heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... 2011 Spherix Incorporated (NASDAQ: SPEX ) ... metabolic syndrome and atherosclerosis, and providers of technical and ... companies -- today announced that Dr. Claire Kruger, Chief ... presenting a corporate overview at the Rodman & Renshaw ...
... Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals ... Executive Officer, will present at the Rodman and Renshaw ... 2:25pm ET at the Waldorf Astoria Hotel in New ... Founded in 2008, Omthera Pharmaceuticals, Inc. ...
Cached Medicine Technology:Spherix Incorporated to Present at the Rodman & Renshaw 13th Annual Healthcare Conference 2
... SuperAnchors are titanium alloy implants ... to bone. They are indicated ... required. The SuperAnchor uses four ... while maintaining small size. The ...
The Mini-Revo suture anchor is designed primarily for arthroscopic and open Bankart shoulder repair. Additional applications include other shoulder repair procedures, as well as use in small joints....
... protection' -- providing complete protection from initial ... with side branches. , ,Proxis is ... not require the attachment or exchange of ... ,Proxis is compatible with all standard ...
... electrophysiology system on the market today, the ... patented "C inside a C" design offering ... ultimate in patient access and flexibility. Usable ... minimizes equipment footprint and can be parked ...
Medicine Products: